×
Risperidone for Severe Tardive Dyskinesia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study PDF
$ 40.00
Risperidone for Severe Tardive Dyskinesia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study PDF quantity
$ 40.00
×
Depression, Obesity, and Metabolic Syndrome: Prevalence and Risks of Comorbidity in a Population-Based Representative Sample of Mexican Americans PDF
$ 40.00
Depression, Obesity, and Metabolic Syndrome: Prevalence and Risks of Comorbidity in a Population-Based Representative Sample of Mexican Americans PDF quantity
$ 40.00
×
Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine PDF
$ 40.00
Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine PDF quantity
$ 40.00
×
A Single-Blind, Randomized Trial Comparing Quetiapine and Haloperidol in the Treatment of Tardive Dyskinesia PDF
$ 40.00
A Single-Blind, Randomized Trial Comparing Quetiapine and Haloperidol in the Treatment of Tardive Dyskinesia PDF quantity
$ 40.00
×
Efficacy and Tolerability of Ziprasidone Versus Risperidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: An 8-Week, Double-Blind, Multicenter Trial PDF
$ 40.00
Efficacy and Tolerability of Ziprasidone Versus Risperidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: An 8-Week, Double-Blind, Multicenter Trial PDF quantity
$ 40.00
×
e-Etiquette PDF
$ 40.00
e-Etiquette PDF quantity
$ 40.00
×
Gepirone Extended-Release in the Treatment of Adult Outpatients With Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study PDF
$ 40.00
Gepirone Extended-Release in the Treatment of Adult Outpatients With Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study PDF quantity
$ 40.00
×
A Naturalistic Comparison of Clozapine, Risperidone, and Olanzapine in the Treatment of Bipolar Disorder PDF
$ 40.00
A Naturalistic Comparison of Clozapine, Risperidone, and Olanzapine in the Treatment of Bipolar Disorder PDF quantity
$ 40.00
×
Use of the ECHO Model to Improve Outcomes for Depressed Patients During the Era of COVID-19 PDF
$ 40.00
Use of the ECHO Model to Improve Outcomes for Depressed Patients During the Era of COVID-19 PDF quantity
$ 40.00
×
Double-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients PDF
$ 40.00
Double-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients PDF quantity
$ 40.00
×
Serotonin Transporter Gene Status and Electroconvulsive Therapy Outcomes: A Retrospective Analysis of 83 Patients PDF
$ 40.00
Serotonin Transporter Gene Status and Electroconvulsive Therapy Outcomes: A Retrospective Analysis of 83 Patients PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
